TGFB1 and breast cancer: In MCF-7 and MDA-MB-231 breast cancer cells, exosome-mediated miR-155 induces chemoresistance through increasing EMT markers and targeting TGF-β, FOXO-3a and C/EBP-β mRNA [104].